Late-onset systemic sclerosis-a systematic survey of the EULAR scleroderma trials and research group database

Rheumatology

Volumn 50, Issue 1, 2011, Pages 161-165

  Hügle, Thomas ^a   Schuetz, Philipp ^b   Daikeler, Thomas ^c   Tyndall, Alan ^c   Matucci Cerinic, Marco ^d   Walker, Ulrich A ^c   van Laar, Jacob M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Elderly; EULAR scleroderma trials and research; Geriatric; Late onset; Scleroderma; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; SCL 70 ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; ECHOCARDIOGRAPHY; FACTUAL DATABASE; FEMALE; FOLLOW UP; FOOT ULCER; HEALTH SURVEY; HUMAN; HYPERTENSION; LATE ONSET SYSTEMIC SCLEROSIS; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MODIFIED RODNAN'S SKIN SCORE; MORTALITY; MULTIVARIATE ANALYSIS; ONSET AGE; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SCORING SYSTEM; SURVIVAL TIME; SYSTEMIC SCLEROSIS;

EID: 79951707914     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq321     Document Type: Article

References (12)

1. Scalapino K, Arkachaisri T, Lucas M et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol 2006;33:1004-13.
2. Walker UA, Tyndall A, Czirjak L et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007;66: 754-63.
3. Mayes MD, Lacey JV Jr, Beebe-Dimmer J et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
4. Bryan C, Knight C, Black CM, Silman AJ. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999;42:2660-5.
5. Czirjak L, Nagy Z, Szegedi G. Systemic sclerosis in the elderly. Clin Rheum 1992;11:483-5.
6. Dalziel JA, Wilcock GK. Progressive systemic sclerosis in the elderly. Postgrad Med J 1979;55:192-3.
7. Derk CT, Artlett CM, Jimenez SA. Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study. Clin Rheum 2006;25: 831-4.
8. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
9. Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest 2009;136:37-43.
10. Appenzeller S, Pereira DA, Costallat LT. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study. Lupus 2008;17:1023-8.
11. Csiki Z, Galuska L, Garai I et al. Raynaud's syndrome: comparison of late and early onset forms using hand perfusion scintigraphy. Rheumatol Int 2006;26:1014-8.
12. Friedman EI, Taylor LM Jr, Porter JM. Late-onset Raynaud's syndrome: diagnostic and therapeutic considerations. Geriatrics 1988;43:59-63, 7-70.